The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Tumor Microenvironment and Differential Responses to Therapy
Open accessAbstract
Cancer evolution plays a key role in both the development of tumors and their response to therapy. Like all evolutionary processes, tumor evolution is shaped by the environment. In tumors, this consists of a complex mixture of nontransformed cell types and extracellular matrix. Chemotherapy or radiotherapy imposes further strong selective pressures on cancer cells during cancer treatment. Here, we review how different components of the tumor microenvironment can modulate the response to chemo- and radiotherapy. We further describe how therapeutic strategies directly alter the composition, or function, of the tumor microenvironment, thereby further altering the selective pressures to which cancer cells are exposed. Last, we explore the consequences of these interactions for therapy outcomes and how to exploit our increasing understanding of the tumor microenvironment for therapeutic benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both conventional DNA damaging chemotherapy and radiotherapy can trigger changes in CAF biology, with fibrosis being a common late side effect of radiotherapy151.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [151]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 420
Tumor microenvironment: A playground for cells from multiple diverse origins
Bharadwaj, D., & Mandal, M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189158 · Cited by 13
Saetang, J., Tedasen, A., Sangkhathat, S., Sangkaew, N., Dokduang, S., Prompat, N., Taraporn, S., & Graidist, P. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.2018470 · Cited by 13
The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment
Hassanian, H., Asadzadeh, Z., Baghbanzadeh, A., Derakhshani, A., Dufour, A., Khosroshahi, N. R., Najafi, S., Brunetti, O., Silvestris, N., & Baradaran, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938063 · Cited by 12
Kudo, K., Yoneda, A., Sakiyama, D., Kojima, K., Miyaji, T., Yamazaki, M., Yaita, S., Hyodo, T., Satow, R., & Fukami, K. (2018) · The FASEB Journal · doi:10.1096/fj.201800664rr · Cited by 12
Jiang, Y., Liu, Y., Huang, H., Zhao, T., Zhao, Z., & Gao, Y. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03926-9 · Cited by 11
Xu, Y., Wang, T., Liang, X., Yang, J., Zhang, Y., & Bao, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571800 · Cited by 12
Sultan, M. H., Zhang, Q., Wang, Y., Xia, Y., & Jia, X. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5545 · Cited by 11
Decoding the Roles of Astrocytes and Hedgehog Signaling in Medulloblastoma
Duarte, T. T., Teixeira, S. A., Gonzalez‐Reyes, L. E., & Reis, R. M. (2021) · Current Oncology · doi:10.3390/curroncol28040267 · Cited by 10
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo
Yu, T., Cao, J., Eddine, M. A., Moustafa, M., Möck, A., Erkut, C., Abdollahi, A., Warta, R., Unterberg, A. W., Herold‐Mende, C. C., et al. (2021) · Cancers · doi:10.3390/cancers13235898 · Cited by 11
Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy
Nadukkandy, A. S., Ganjoo, E., Singh, A. K., & Kumar, L. D. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.911063 · Cited by 12
Bhaoighill, M. N., Falcón-Perez, J., Royo, F., Tee, A., Webber, J., & Dunlop, E. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12336 · Cited by 9
Balasubramani, G., Muthu, M., Gopal, J., & Chun, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127162 · Cited by 11
Khadirnaikar, S., Shukla, S. K., & Prasanna, S. R. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287176 · Cited by 11
Experimental pathology by intravital microscopy and genetically encoded fluorescent biosensors
Matsuda, M., & Terai, K. (2020) · Pathology International · doi:10.1111/pin.12925 · Cited by 11
Smart Drug Delivery Strategies for Cancer Therapy
Mendoza, C. M. L., & Alcántara-Quintana, L. E. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2021.753766 · Cited by 11
Targeting oncogenic signal pathway to improve cancer immunotherapy: Insights and perspectives
Yang, Q., Sun, H., & Sun, Z. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117043 · Cited by 11
Alizamir, A., Azad, S. D., Pirdehghan, A., & Moradi, A. (2022) · Iranian journal of pathology · doi:10.30699/ijp.2022.539042.2727 · Cited by 10
Westwood, L., Nixon, I. J., Emmerson, E., & Callanan, A. (2024) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2024.1347324 · Cited by 11
Weijie, S. (2024) · Discover Oncology · doi:10.1007/s12672-024-01693-8 · Cited by 10
Sun, S., Qu, Y., Wen, F., & Yu, H. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0583 · Cited by 10
Jules, A., Means, D., Troncoso, J. R., Fernandes, A., Dadgar, S., Siegel, E. R., & Rajaram, N. (2022) · Radiation Research · doi:10.1667/rade-21-00228.1 · Cited by 10
Yu, H., Qin, X.-K., Yin, K.-W., Li, Z.-M., Ni, E.-D., Yang, J., Liu, X.-H., Zhou, A., Li, S.-J., Gao, T., et al. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad041 · Cited by 11
Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment
Zhang, N., Zhou, J., Li, S., Cai, W., Ru, B., Hu, J., Liu, W., Liu, X., Tong, X., & Zheng, X. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00846 · Cited by 11
Kou, Z., Liu, C., Zhang, W., Sun, C., Liu, L., & Zhang, Q. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5642 · Cited by 11
Donnelly, K., Papich, M. G., Zirkelbach, B., Norton, T. M., Szivek, A., Burkhalter, B., Impellizeri, J. A., & Stacy, N. I. (2019) · Journal of Aquatic Animal Health · doi:10.1002/aah.10067 · Cited by 10
Chhetri, A., Rispoli, J. V., & Lelièvre, S. A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.628386 · Cited by 11
Wang, W., Wang, L., She, J., & Zhu, J. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0762 · Cited by 11
Yang, L., Li, J., Jiang, H., & Li, X. (2021) · Disease Markers · doi:10.1155/2021/5669635 · Cited by 10
Charalampakis, N., Tsakatikas, S. A., Schizas, D., Kykalos, S., Tolia, M., Fioretzaki, R., Papageorgiou, G., Katsaros, I., Abdelhakeem, A. A. F., Sewastjanow‐Silva, M., et al. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.181 · Cited by 10
Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma
Su, K., Peng, Y., & Yu, H. (2022) · Disease Markers · doi:10.1155/2022/9141117 · Cited by 10
The tumor microenvironment in therapy resistance
Garcia, G., Schmidt, C. J., & Hajal, C. (2024) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2024.1420233 · Cited by 10
Córdoba, L., Cueto, F. J., Cantero-Cid, R., Moret, R., Díaz, E., Alvarez-Benayas, J., Fernández-Felipe, J., Jiménez-Rodríguez, J., Arvelo-Rosario, D., Mata-Martínez, P., et al. (2025) · Cancers · doi:10.3390/cancers18010132 · Cited by 10
Ranek, J. S., Greenwald, N. F., Goldston, M., Fullaway, C. C., Sowers, C., Kong, A., Mouron, S. A., Quintela-Fandiño, M., West, R. B., Bendall, S. C., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01122-5 · Cited by 12
Prometastatic Effect of ATX Derived from Alveolar Type II Pneumocytes and B16-F10 Melanoma Cells
Dacheux, M. A., Lee, S. Ç., Shin, Y., Norman, D. D., Lin, K., Shuyu, E., Yue, J., Benyó, Z., & Tigyi, G. (2022) · Cancers · doi:10.3390/cancers14061586 · Cited by 9
A spatial perspective on bacteria in tumours
Livyatan, I., & Straussman, R. (2022) · Nature · doi:10.1038/d41586-022-03669-6 · Cited by 9
Guo, Y., Zhang, Y., Cen, K., Dai, Y., Mai, Y., & Hong, K. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125203 · Cited by 8
Chen, D., Li, X., Wang, Y., Li, X., Zhang, H., Zhang, L., Yang, J., Tan, H., Xie, Y., Liuzhou, Y., et al. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20230040 · Cited by 9
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis
Qin, F., Xu, Z., Yuan, L., Chen, W., Wei, J., Sun, Y., & Li, S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12934 · Cited by 9
Qin, M., Xu, M., Niu, L., Cheng, Y., Niu, X., Kong, J., Zhang, X., Wei, Y., & Huang, D. (2021) · Frontiers of Materials Science · doi:10.1007/s11706-021-0543-y · Cited by 9
Wan, Y., Wang, Z., Yang, N., & Liu, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.911961 · Cited by 9
Effective dose window for containing tumor burden under tolerable level
Masud, M. A., Kim, J., & Kim, E. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00279-4 · Cited by 9
Microenvironment in Cardiac Tumor Development: What Lies Beyond the Event Horizon?
Mylonas, K. S., Ziogas, I. A., & Avgerinos, D. V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36214-0_4 · Cited by 9
Kagan, J., Moritz, R. L., Mazurchuk, R. V., Lee, J. H., Kharchenko, P. V., Rozenblatt–Rosen, O., Ruppin, E., Edfors, F., Ginty, F., Goltsev, Y., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00021 · Cited by 8
Huppert, L. A., Fisch, S. C., Tsopurashvili, E., Somepalle, S. S., Salans, M. A., Vasudevan, H. N., Chien, A. J., Majure, M. C., Rugo, H. S., Balassanian, R., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07339-1 · Cited by 11
The Role of Nanoscience in Cancer Diagnosis
Guerrini, L., García‐Rico, E., & Álvarez‐Puebla, R. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813339-2.00007-4 · Cited by 8
Humanized Patient-Derived Xenograft Models of Ovarian Cancer
Gitto, S. B., George, E. M., Medvedev, S., Simpkins, F. A., & Powell, D. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1956-8_17 · Cited by 8
Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma
Xu, X., Chen, D., Feng, X., Hu, J., Ge, J., Yan, C., Zhang, D., Ling, Z., Chen, J., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.654689 · Cited by 8
Nicaraven prevents the fast growth of inflamed tumors by an anti-inflammatory mechanism
Abdelghany, L., Zhang, X., Kawabata, T., Goto, S., El‐Mahdy, N. A., Jingu, K., & Li, T. (2021) · Medical Oncology · doi:10.1007/s12032-021-01602-x · Cited by 8
Patient-Derived Explant Cultures of Normal and Tumor Human Breast Tissue
Gris-Cárdenas, I., Rábano, M., & Vivanco, M. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2193-6_17 · Cited by 8
Zhou, N., Tang, Q., Yu, H., Li, T., Ren, F., Zu, L., Chen, G., Chen, J., & Xu, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1034208 · Cited by 8
Vidiri, A., Ascione, A., Piludu, F., Polito, E., Gallo, E., Covello, R., Nisticò, P., Balzano, V., Pichi, B., Pellini, R., et al. (2022) · Cancers · doi:10.3390/cancers15010015 · Cited by 8
Liang, X., Du, L., & Fan, Y. (2023) · Aging · doi:10.18632/aging.204766 · Cited by 8
The Yin and Yang of Breast Cancer: Ion Channels as Determinants of Left–Right Functional Differences
Masuelli, S., Real, S., McMillen, P. T., Oudin, M. J., Levin, M. G., & Roqué, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311121 · Cited by 8
Machireddy, A., Thibault, G., Loftis, K. G., Stoltz, K., Bueno, C. E., Smith, H., Riesterer, J. L., Gray, J. W., & Song, X. B. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1308708 · Cited by 8
Mejia, I., Bodapati, S., Chen, K. T., & Díaz, B. (2020) · Biomedicines · doi:10.3390/biomedicines8100401 · Cited by 9
Ring, B. Z., Cronister, C. T., Ring, H. Z., Ross, D. T., & Seitz, R. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-83915-1 · Cited by 7
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection
Gupta, J., Jalil, A. T., Alzahraa, Z. H. A., Aminov, Z., Alsaikhan, F., Ramírez‐Coronel, A. A., Ramaiah, P., & Najafi, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230703143907 · Cited by 7
Alnassar, N., Derry, J. M. J., Banna, G. L., & Górecki, D. C. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-28 · Cited by 7
Single-cell signatures identify microenvironment factors in tumors associated with patient outcomes
Xue, Y., Friedl, V., Ding, H., Wong, C. K., & Stuart, J. M. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100799 · Cited by 7
Interleukin-33 (IL-33) promotes DNA damage-resistance in lung cancer
Luo, H., Liu, L., Liu, X., Xie, Y., Huang, X., Yang, M., Shao, C., & Li, D. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07624-x · Cited by 7
Role of the Bone Marrow Microenvironment in Drug Resistance of Hematological Malignances
Hosseini, A., Hamblin, M. R., Mirzaei, H., & Mirzaei, H. R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210910124319 · Cited by 7
Fan, J., Feng, Y., Cheng, Y., Wang, Z., Zhao, H., Galan, E. A., Liao, Q., Cui, S., Zhang, W., & Ma, S. (2021) · Patterns · doi:10.1016/j.patter.2021.100360 · Cited by 7
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
Kraus, F. B. T., Topalov, N. E., Deuster, E., Hysenaj, I., Mayr, D. C., Chelariu-Raicu, A., Beyer, S., Kolben, T., Burges, A., Mahner, S., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04114-x · Cited by 7
Dynamic contrast-enhanced computed tomography in dogs with nasal tumors
Mortier, J. R., Maddox, T. W., Blackwood, L., Fontaine, M. D. L., & Busoni, V. (2023) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16722 · Cited by 7
Watanabe, D., Fujii, H., Ohata, K., Iihara, H., Makiyama, A., Kobayashi, R., Hirose, C., Sadaka, S., Matsuoka, S., Tajima, J. Y., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11618-3 · Cited by 7
QUICHE reveals structural definitions of anti-tumor responses in triple negative breast cancerPreprint
Ranek, J. S., Greenwald, N. F., Goldston, M., Fullaway, C. C., Sowers, C., Kong, A., Mouron, S. A., Quintela-Fandiño, M., West, R. B., & Angelo, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.06.631548 · Cited by 6
Tang, Y., Wang, H., Zhang, J., Yang, C., Xu, F., Song, Y., Li, T., & Zhang, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-86185-7 · Cited by 6
Classification and Treatment of Diseases in the Age of Genome Medicine Based on Pathway Pathology
Petersen, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179418 · Cited by 6
Exploring the macromolecules for secretory pathway in cancer disease
Selvaraj, C., Panwar, U., Ramalingam, K. R., Vijayakumar, R., & Singh, S. K. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.003 · Cited by 7
On the contribution of mass spectrometry-based platforms to the field of personalized oncology
Orlando, E., & Aebersold, R. H. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.10.018 · Cited by 7
Wang, Y.-C., Dai, Y., Xu, G., Yu, W., Quan, R.-L., & Zhao, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.923409 · Cited by 7
Primary tumor cell cultures: сurrent methods of obtaining and subcultivation
Межевова, И. В., Sitkovskaya, A. О., & Kit, O. I. (2020) · South Russian Journal of Cancer · doi:10.37748/2687-0533-2020-1-3-4 · Cited by 6
Hongo, T., Kuga, R., Miyazaki, M., Komune, N., Nakano, T., Yamamoto, H., Koike, K., Sato, K., Kogo, R., Nabeshima, K., et al. (2021) · The Laryngoscope · doi:10.1002/lary.29689 · Cited by 7
Qin, M., Ma, Y., Wang, Z., Fang, D., & Wei, J. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-783 · Cited by 6
Li, N., Yu, K., Zhong, L., & Zeng, D. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211053588 · Cited by 6
Trono, P., Sistigu, A., Palermo, B., Ciliberto, G., & Nisticò, P. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170068 · Cited by 6
Shimonov, S., Cunningham, J. M., Talmon, R., Aizenbud, L., Desai, S. J., Rimm, D. L., Schalper, K. A., Kluger, H. M., & Kluger, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.30.573739 · Cited by 5
SetQuence & SetOmic: Deep Set Transformer-based Representations of Cancer Multi-Omics
Jurenaite, N., León-Periñán, D., Donath, V., Torge, S., & Jäkel, R. (2022) · 2022 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) · doi:10.1109/cibcb55180.2022.9863058 · Cited by 5
Wang, M., Li, J., Qian, J., Zhang, X., Li, M., Zhao, Y., Wang, Z., Guo, K., Gao, D., Zhao, Y., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70509 · Cited by 8
Wang, J., Chen, S., Wang, H., Cao, J., Fan, X., Man, J., Li, Q., & Li, Y. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12102 · Cited by 6
Sikorska, M., Domański, G., Bamburowicz‐Klimkowska, M., Kasprzak, A., Nowicka, A. M., Ruzycka-Ayoush, M., & Grudziński, I. P. (2024) · Cancer Nanotechnology · doi:10.1186/s12645-024-00276-0 · Cited by 5
Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality
Grandits, M., Palhares, L. C. G. F., Macleod, O. J. S., Devlin, J. W., Amin, O. E., Birtley, J. R., Partington, L., Wilson, T., Hardaker, E. L., Karagiannis, S. N., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2502673 · Cited by 5
Wong, C. H. L., Chan, S.-K., Lo, R. C., & Chiang, C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104842 · Cited by 5
Liu, C., Cong, X., Wang, Y., Guo, Q., Xie, Y., Geng, F., Guo, J., Dong, L., Zhou, Y., Wu, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.752444 · Cited by 5
Immune signatures of CD4 and CD68 predicts disease progression in cutaneous T cell lymphoma.
Huang, S., Liao, M., Chen, S., Zhang, P., Xu, F., & Zhang, H. (2022) · PubMed Central · Cited by 5
Preclinical Models of Meningioma
Jungwirth, G., Hanemann, C. O., Dunn, I. F., & Herold‐Mende, C. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-29750-2_15 · Cited by 5
SetQuence & SetOmic: Deep set transformers for whole genome and exome tumour analysis
Jurenaite, N., León-Periñán, D., Donath, V., Torge, S., & Jäkel, R. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.105095 · Cited by 5
Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes
Chen, J., Kang, Z., Li, S., Wang, C., Zheng, X., Cai, Z., Pan, L., Chen, F., & Li, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911260 · Cited by 5
Xu, B., Tseng, I., Zhang, X., Chen, H., del Campo, E. R., Deng, J., Ai, D., Fang, X., Sun, X., Zhao, K., et al. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-317 · Cited by 4
An, D., He, P., Liu, H., Wang, R., Yu, X., Chen, N., Guo, X., Li, X., & Feng, M. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2276664 · Cited by 5
Single Cell Sequencing: A New Dimension in Cancer Diagnosis and Treatment
Wu, F., Fan, J., Fang, J., Dalvi, P. S., Odenthal, M., & Fang, N. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4494-1_9 · Cited by 5
Gottlieb, B., Babrzadeh, F., Oros, K. K., Alvarado, C., Wang, C., Gharizadeh, B., Basik, M., Greenwood, C. M. T., Beitel, L. K., & Trifiro, M. A. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.26 · Cited by 5
Deep learning: shaping the medicine of tomorrow
Vougas, K. N., Almpanis, S., & Gorgoulis, V. G. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1723462 · Cited by 5
Machireddy, A., Thibault, G., Loftis, K. G., Stoltz, K., Bueno, C. E., Smith, H. R., Riesterer, J. L., Gray, J. W., & Song, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.27.446019 · Cited by 5
Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcomePreprint
Bertillot, F., Hervé, S., Drobjazko, N., Kedei, N., Gendi, M. A. E., Hernandez, M. O., Kruse, K., Erkan, E. P., Binner, M., Punovuori, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.11.669722 · Cited by 5
Kim, Y., Jeon, S. H., Kim, S., Kang, M. H., Han, M. G., Lee, S. Y., & Kim, I. A. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110480 · Cited by 4
Kiiamova, M. R., Антонова, Е. И., Firsova, N. V., Lengesova, N. A., Bezrukova, U. A., & Сихарулидзе, С. В. (2022) · Fundamental and Applied Research for Key Propriety Areas of Bioecology and Biotechnology · doi:10.31483/r-102248 · Cited by 4
sasha, Y., Lu, S. T., Gao, H., Song, Q., & Li, L. (2023) · Physica Scripta · doi:10.1088/1402-4896/ad190b · Cited by 4
Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine
Díaz-Gavela, A. A., Peñalver, E. D. C., Sánchez-García, S., Guerrero, L. L., Sanz‐Rosa, D., & Couñago, F. (2021) · Breast Disease · doi:10.3233/bd-201022 · Cited by 4
Milne, A., Marusyk, A., Maini, P. K., Anderson, A. R. A., & Picco, N. (2025) · Communications Biology · doi:10.1038/s42003-025-08585-9 · Cited by 7
Metadata
- Authors
- Hirata, E., & Sahai, E.
- Affiliations
- Kanazawa Medical University (JP)
- The Francis Crick Institute (GB)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-02-17
- Volume
- 7
- Issue
- 7
- Pages
- a026781
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC5495051
- OpenAlex
- W2588118089
- Cited by
- 422
- References
- 130
- Citations by year
- 2026: 30 · 2025: 38 · 2024: 49 · 2023: 52 · 2022: 58 · 2021: 84 · 2020: 64 · 2019: 31 · 2018: 10 · 2017: 5
- Type
- posted content
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Francis Crick Institute (10144)
- Japan Society for the Promotion of Science (17K07181)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor microenvironment, tumor evolution, chemotherapy response, radiotherapy response, extracellular matrix, selection pressure, treatment options, cancer therapy outcomes
- MeSH terms
- Drug Therapy, Extracellular Matrix, Humans, Neoplasms, Radiotherapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
